A detailed history of Maven Securities LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Maven Securities LTD holds 8,981 shares of MRK stock, worth $893,160. This represents 0.13% of its overall portfolio holdings.

Number of Shares
8,981
Previous 14,090 36.26%
Holding current value
$893,160
Previous $1.74 Million 41.57%
% of portfolio
0.13%
Previous 0.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $567,865 - $658,907
-5,109 Reduced 36.26%
8,981 $1.02 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $1.41 Million - $1.51 Million
-11,381 Reduced 44.68%
14,090 $1.74 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $2.88 Million - $3.36 Million
25,471 New
25,471 $3.36 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $1.52 Million - $1.69 Million
14,812 Added 84.69%
32,302 $3.33 Million
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $1.9 Million - $2.07 Million
17,490 New
17,490 $2.02 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1.38 Million - $1.55 Million
16,342 Added 503.76%
19,586 $16.9 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $23,043 - $26,120
276 Added 9.3%
3,244 $296,000
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $218,177 - $244,563
2,968 New
2,968 $244,000
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $574,801 - $632,137
-8,019 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $563,815 - $623,637
8,019 New
8,019 $624,000
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $341,384 - $386,961
-4,665 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $328,509 - $373,806
4,665 New
4,665 $361,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.